olaparib,bevacizumab
Merck,roche,AstraZeneca
['lynparza', 'bevacizumab', 'ovarian', 'astrazeneca', 'merck']
#astrazeneca and #merck reported #lynparza in combination with #bevacizumab and as #monotherapy demonstrates clinically meaningful long-term survival in certain patients with 1l advanced #ovariancancer in exploratory analyses of two phase 3 trials #esmo22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.